
ORTHOPEDIATRICS CORP
Nasdaq · Surgical & Medical Instruments & Apparatus
Company Overview
A concise company profile alongside the latest public filing activity.
OrthoPediatrics Corp designs, manufactures, and markets orthopedic implants, instruments, and devices used specifically to treat pediatric orthopedic conditions, including deformity correction, trauma, and scoliosis, selling primarily to hospitals and surgeons through a direct sales force and distributor network.
Company profile sourced from SEC filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| Pelizzon David RDirector | Sell | $525K | 22,500at $23.35 | Sep 2, 2026 |
| Squadron Capital LLCInsider | Sell | $7.53M | 326,700at $23.04 | Aug 28, 2026 |
| Squadron Capital LLCInsider | Sell | $234K | 10,131at $23.10 | Sep 1, 2026 |
| Pritzker Jennifer N.Insider | Sell | $7.53M | 326,700at $23.04 | Aug 28, 2026 |
| Pritzker Jennifer N.Insider | Sell | $234K | 10,131at $23.10 | Sep 1, 2026 |
| Pelizzon David RDirector | Sell | $403K | 16,300at $24.74 | Aug 25, 2026 |
| Pritzker Jennifer N.Insider | Sell | $103K | 4,000at $25.75 | Aug 24, 2026 |
| Pritzker Jennifer N.Insider | Sell | $437K | 18,000at $24.28 | Aug 26, 2026 |
| Pelizzon David RDirector | Sell | $103K | 4,000at $25.75 | Aug 24, 2026 |
| Squadron Capital LLCInsider | Sell | $103K | 4,000at $25.75 | Aug 24, 2026 |
| Squadron Capital LLCInsider | Sell | $437K | 18,000at $24.28 | Aug 26, 2026 |
| Pelizzon David RDirector | Sell | $437K | 18,000at $24.28 | Aug 26, 2026 |
| Pritzker Jennifer N.Insider | Sell | $403K | 16,300at $24.74 | Aug 25, 2026 |
| Squadron Capital LLCInsider | Sell | $403K | 16,300at $24.74 | Aug 25, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable KIDS activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.